Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease. - Wikidata - awgldk - TriplyDB

Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease.

Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease.

http://www.wikidata.org/entity/Q42682524

about

Smart nanosystems: Bio-inspired technologies that interact with the host environment Engineering opportunities in cancer immunotherapy Evolving therapies for liver fibrosis.Nanotechnology in radiation oncology.Disease detection by ultrasensitive quantification of microdosed synthetic urinary biomarkers.Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis.Ensembles of protein termini and specific proteolytic signatures as candidate biomarkers of disease.Detecting cancers through tumor-activatable minicircles that lead to a detectable blood biomarker.New Methods in Tissue Engineering: Improved Models for Viral Infection Array-based sensing using nanoparticles: an alternative approach for cancer diagnostics.Programmable probiotics for detection of cancer in urine.Exogenous marker-engineered mesenchymal stem cells detect cancer and metastases in a simple blood assay.Mathematical framework for activity-based cancer biomarkers.Pulsed Azidohomoalanine Labeling in Mammals (PALM) Detects Changes in Liver-Specific LKB1 Knockout Mice.Gold nanoparticle-based activatable probe for sensing ultralow levels of prostate-specific antigen.Nanotechnology: emerging tools for biology and medicine Point-of-care diagnostics for noncommunicable diseases using synthetic urinary biomarkers and paper microfluidics.Integrin αvβ6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis.Tumor metastasis: moving new biological insights into the clinic.Cell and tissue engineering for liver disease.Cancer proteomics: developments in technology, clinical use and commercialization.A synthetic urinary probe-coated nanoparticles sensitive to fibroblast activation protein α for solid tumor diagnosis.Photoactivated Spatiotemporally-Responsive Nanosensors of in Vivo Protease Activity.Circulating peptidome to indicate the tumor-resident proteolysis.A Model-Based Personalized Cancer Screening Strategy for Detecting Early-Stage Tumors Using Blood-Borne Biomarkers.In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease.Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal.Blood Droplet-Based Cancer Diagnosis via Proteolytic Activity Measurement in Cancer Progression.Magnetically Actuated Protease Sensors for in Vivo Tumor Profiling Mechanisms of cooperation in cancer nanomedicine: towards systems nanotechnology.Biomimetically Engineered Demi-Bacteria Potentiate Vaccination against Cancer.Stimuli-sensitive intrinsically disordered protein brushes.Engineered Livers for Infectious Diseases.In Vivo Biosensing: Progress and Perspectives.Synthetic Biomarker Design by Using Analyte-Responsive Acetaminophen.Microfluidic chip coupled with modified paramagnetic particles for sarcosine isolation in urine.Sustained-release synthetic biomarkers for monitoring thrombosis and inflammation using point-of-care compatible readouts.Towards clinically translatable in vivo nanodiagnostics.Improvement of enzyme-linked immunosorbent assay for the multicolor detection of biomarkers.

P2860

Q26776370-0AFEDD55-C62A-4498-8084-AA1B860ECCC5 Q26776373-72F9016A-91B3-4C11-B679-B1A422E51427 Q30539166-35823A8A-B9B1-41CE-851B-05BEB56BAF55 Q34124280-7608B2B5-51C7-430E-851B-E05BAD5C0A81 Q34282732-82FE1CDC-E38C-402F-8286-56EB1D27244E Q34369626-8D13A02F-1D6C-4221-B2CB-EDE2A772DC5D Q34402330-CF0F9E9E-4655-49B0-A772-822C83C7E759 Q35190027-A958242D-758B-460B-BFEF-13062847DB3D Q35431256-89BA1269-5496-455F-A5B4-3B68A77B037F Q35621579-2A8046D7-C569-4921-AFEF-4314BB36D61C Q35879638-F9D48E98-5E11-43EC-A2CD-8DD352CFA2C4 Q36082553-B57D01C2-7E84-428E-B23A-0BE2D3510923 Q36179245-1D92BFDD-7364-48A0-8EBB-B51337AE1CB2 Q36272558-7B27EE98-F3A1-461F-A076-CD6D434C6D3B Q36966723-374C34BA-B2DF-4749-AC49-9BAC1B996A90 Q37345819-1AEE9C87-C455-40CD-8AF9-AA947A431EBC Q37640983-4BEF9716-2086-49EA-A4A3-6BE288364D9B Q37644463-1388C09A-D76C-407A-9E09-329B64B55D2E Q38160740-AF13D027-A489-4CAD-A147-3D0AD02213B7 Q38230357-2FBED76D-A659-4201-AC05-5962E097E850 Q38543009-7974BF93-7982-42DF-B370-7287271BCCDC Q38695282-C3B87A4C-94C3-4330-B147-ECA7F95A8F0E Q38819699-687530E6-5458-4C6C-885E-6AB6DD78FB4F Q38897705-A3642BD0-52D1-4EF1-860E-44A9B1437D3C Q38913999-45AF6520-BE05-4987-93DF-68090D79E3F2 Q40116179-DABC6E68-C6CD-4F8D-B7DA-5CB2496414B5 Q41449567-A720AFB2-CF77-4E49-8D1E-7AE575FE796F Q41455503-54D2283C-80BB-4B6E-A8F5-630CEC02C220 Q42011638-2515082B-D1A9-422E-8118-26361D569439 Q42145728-E224AE94-4327-4F8D-BFF6-E3372786386D Q42379305-DB8F3F03-F284-4E39-BA57-3C9FC1AA23C5 Q43703724-E463214E-5E9D-45C9-8671-A315984C8B10 Q47555660-067E9DF6-A5DC-46D7-8B09-306B9A8E6EB4 Q47907365-441093AC-A469-44BD-8F9D-9E6B91D1FFBA Q48822089-D6B4FF64-E107-48F0-8FF5-414C04673295 Q51530672-5F665F9F-1C49-4D91-BF88-E9CC582DC81D Q54606553-EC100DFA-51E6-4F44-8253-F0CD9D17C422 Q54985361-56EF6EE2-D4EC-42E4-B04F-90136BA34127 Q55634378-766B23E3-AB78-43BB-A811-F0E2805CB97C

P2860

Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease.

http://www.wikidata.org/entity/Q42682524

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease.

@en

Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease.

@nl

type

label

Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease.

@en

Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease.

@nl

prefLabel

Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease.

@en

Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease.

@nl

P1433

Q42682524-1EAB6F00-E186-4D8C-A0DD-3405DC6CF11B

P1476

Q42682524-FC98AC37-433F-483E-82E7-777D02606BA4

P2093

Q42682524-01620A41-3096-4F17-97CA-B16C1EFB1E71

Q42682524-24EAD465-E96C-4082-A5AE-75E7D4659305

Q42682524-58A0243F-FD23-4606-959E-26BDE856228C

Q42682524-81AC5375-A0D4-43D3-B468-656607568B84

Q42682524-83E13160-319B-4945-985C-DDAD5DDA8904

Q42682524-A3256011-73B6-421E-92A1-AA9A7CE36A62

Q42682524-A3D6476E-BAB3-4083-B3D1-401433238097

Q42682524-A7EA796A-3026-4EDC-93DD-0D035C965D19

Q42682524-DE48DBDD-7C52-4976-9739-025F7D1C2737

Q42682524-EA9B9473-52B3-4EFE-8BC6-7B51010F35E0

P2860

Q42682524-0116DF3B-7181-4E1C-8A2C-7E1DF93BEF9E

Q42682524-02AFE19B-5866-4F59-8936-9242082DB639

Q42682524-04573BC6-B381-4FBC-9111-E438E4335DFC

Q42682524-0930FEE8-3397-4073-B870-79E7986BAC58

Q42682524-0A9943C9-C3DD-4B28-8220-A168F9B711A8

Q42682524-181D5A57-2E55-45F7-AAE8-1442B3A88BD2

Q42682524-1E2A6323-F567-4030-8AF9-6098F9C179B1

Q42682524-24BB92B9-6EB6-4C86-A96F-2A4874DB3122

Q42682524-2AC107BA-DDDC-451E-9878-D961BBBD6D63

Q42682524-2FB6824A-B7A9-4F4E-9CB4-3D9F6E6E9449

P2888

Q42682524-832EE312-4D70-407B-8F68-66C8A15C09D0

P304

Q42682524-24D1EC91-7844-419D-8BB4-7A4531757E42

P31

Q42682524-570DD6D3-747D-46D8-8A8B-9150FFB53DD3

P356

Q42682524-5C85B088-5DEF-4D59-977B-D27C4D8347CF

P433

Q42682524-112EC6C2-04BF-4594-AA51-22D0EC93DF00

P478

Q42682524-DEEBBD31-325E-4094-8A21-1C736D37A374

P50

Q42682524-04AD361A-F5CD-41CB-9E9C-30883ECCBC03

P577

Q42682524-F13354FF-F1F5-4397-B424-97514ABA242E

P5875

Q42682524-F92BA8A8-2F64-48C6-B6E2-26697A0DD104

P6179

Q42682524-19601D6F-FF6C-40C5-87FE-36618070B1C7

P698

Q42682524-660DF3BA-2579-4C0E-B682-719F6506B27D

P921

Q42682524-B49FBF49-458E-4F72-9480-E75EC4C43DF0

P932

Q42682524-1D7FB6DB-3170-4BCE-B7FC-55790CB2F929

P356

P1433

Nature Biotechnology

P1476

Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease.

@en

P2093

Andrew D Warren

http://www.w3.org/2001/XMLSchema#string

Deanna Y Sverdlov

http://www.w3.org/2001/XMLSchema#string

Detlef Schuppan

http://www.w3.org/2001/XMLSchema#string

Gabriel A Kwong

http://www.w3.org/2001/XMLSchema#string

Gayathree Murugappan

http://www.w3.org/2001/XMLSchema#string

Geoffrey von Maltzahn

http://www.w3.org/2001/XMLSchema#string

Ioannis A Papayannopoulos

http://www.w3.org/2001/XMLSchema#string

Omar Abudayyeh

http://www.w3.org/2001/XMLSchema#string

Sangeeta N Bhatia

http://www.w3.org/2001/XMLSchema#string

Steven Mo

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of rare circulating tumour cells in cancer patients by microchip technology

Micro-NMR for rapid molecular analysis of human tumor samples

Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations

A strategy for blood biomarker amplification and localization using ultrasound.

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

Renal clearance of quantum dots.

Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review.

Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents

A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis

Determination of protease cleavage site motifs using mixture-based oriented peptide libraries.

P2888

P304

63-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NBT.2464

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233930613

http://www.w3.org/2001/XMLSchema#string

P6179

1029253759

http://www.w3.org/2001/XMLSchema#string

P698

23242163

http://www.w3.org/2001/XMLSchema#string

P921

P932

3542405

http://www.w3.org/2001/XMLSchema#string